VectorBuilder
@VectorBuilder
Followers
1K
Following
806
Media
1K
Statuses
2K
VectorBuilder is a global leader in gene delivery technologies. We are a trusted partner for thousands of labs and biotech/pharma companies around the globe.
Chicago, IL
Joined June 2015
The lights are back on, the lab benches are ready, and the science is officially back in motion. We hope you had time to rest, reset, and maybe even let a few ideas incubate over the break. As we kick off the new year, we’re ready to support your next experiments and
0
0
1
In 2025, VectorBuilder went worldwide 🌍🧬 From lab benches to conference halls across the globe, our team connected with researchers sharing ideas, sparking collaborations, and accelerating discovery. Different cities, different time zones, one mission: pushing science forward,
0
0
0
In 2025, VectorBuilder’s Gene Delivery Seminar Series brought together expert insights, emerging technologies, and practical solutions from across the field. Thanks to our speakers and community for joining us. More to come in 2026!
1
0
0
As the year winds down and experiments pause, we’re grateful for the scientists, collaborators, and innovators who made 2025 a great year. Thank you for building the future of science! *Please note: our offices will be closed December 24–25 and January 1 as we recharge our
0
0
0
Season’s Greetings from the VectorBuilder team! 🎄 Our holiday party was proof that great science comes with even better people. Fun conversations, lots of laughs, and some of the people who make it all happen ✨
0
0
1
Did you catch our GDS Seminar last week? Our latest GDS seminar is now available on our YouTube channel! Dr. Cat Saunders (Senior Applications Specialist at @SpartaBioNano) introduces best practices in nanoparticle characterization, highlighting why consistent, reliable
1
0
0
A little holiday surprise showed up under the VectorBuilder tree 🎄 We’re excited to share that VectorBuilder was named Life Science Sales and Marketing (@LSSMAwards) Awards Marketing Team of the Year. Grateful for this team and the scientific community that inspires our work!
0
0
0
Earlier this year, Dr. Katherine Sadleir and the Vassar lab showed that annexin A6 localizes to dystrophic neurites and reduces neurite burden and phosphorylated tau in AD model mice, supporting further investigation of rA6 to limit Aβ-induced membrane damage. Proud to support
1
0
0
At VectorBuilder, we're proud to build lasting partnerships in science. Thank you to Dr. Angelina Palacios Muñoz from Universidad de Valparaíso (Chile) for this testimonial. We love to hear how our team has helped and supported your research breakthroughs throughout this year!
0
0
1
The VectorBuilder team is headed to Gwangju for the KSIB 2025 Conference! Don't miss a chance to talk with our Territory Managers, Sangwoo Bae and Kay Hwang, about research solutions, tailored for your project needs. Looking forward to seeing you there!
0
1
2
Don't miss! Our seminar with Dr. Cat Saunders (Senior Applications Specialist at SPARTA Biodiscovery) starts today! Join the webinar here: https://t.co/hrzuHrwV27
us06web.zoom.us
Next Generation Particle Analytics: Label-free Insights at the Single-Particle Level In this talk, SPARTA Biodiscovery will walk us through their first-in-class, label-free single particle characte...
Working in drug delivery, gene therapy, or nanoparticle formulation? Our December Gene Deliver Seminar with @SpartaBioNano is for you! Register here! https://t.co/QEYv9CM1Df
0
0
0
And that's a wrap on #CellBio2025! Our team had a great time connecting with you all at our booth. Shout out to our Territory Manager, Morgan Dwyer, for her presentation on "Optimizing lentiviral vector design and production for cell and gene therapies"! Missed us and our new
0
0
0
Curious to see what it really takes to bring your research to the drug development stage? 🧬 Our last Gene Delivery Seminar featured Dr. Andy Merritt, Head of Academic Engagement at LifeArc (@lifearc1) as he unveiled the key roles of academia, industry, and every player in
1
1
2
New @SelectScience article featuring insights from Dr. Alan Griffith, VectorBuilder’s Head of CDMO Operations, on why mechanism of action (MoA)-based potency assays are essential for successful gene therapy development. He explains how MoA-based potency models help teams
selectscience.net
VectorBuilder’s Alan Griffith explains the value of MoA-reflective potency assays for gene therapy development and the benefits of working with assay specialists like Svar Life Science
0
0
0
Attending #CellBio2025? Stop by our Booth #307 and chat with our team to learn about our latest offerings and solutions for your research needs. Be sure to also catch our presentation, "Optimizing lentiviral vector design and production for cell and gene therapies" at Board B488
0
0
1